<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02614079</url>
  </required_header>
  <id_info>
    <org_study_id>Atallah SCS DSSEP</org_study_id>
    <nct_id>NCT02614079</nct_id>
  </id_info>
  <brief_title>Evaluation of the Percutaneous SCS Trial Using the DSSEP Collision Testing</brief_title>
  <official_title>Evaluation of the Percutaneous Spinal Cord Stimulation Trial Using the Dermatomal Somatosensory Evoked Potentials (DSSEP) Collision Testing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Toledo Health Science Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Toledo Health Science Campus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to objectively evaluate the success of a spinal cord stimulator (SCS) trial
      using testing (DSSEP) to determine if the paresthesia (tingling sensation) or pain reduction
      achieved correlates with the degree of stimulation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The SCS trial leads will be placed as per standard of care, using fluoroscopic guidance and
      leads will be checked for proper positioning. Leads will be tested for appropriate
      paresthesia coverage of the patient's painful area(s), using multiple electrode
      configurations and lead positions (dependent on the location of the pain). After the leads
      are secured, the patient will be sent to the recovery room where the DSSEP test will be
      performed. A technologist will glue/tape recording electrodes to the patient's head, neck,
      back or legs. One or two stimulating electrodes are also placed on the patient's leg. Each
      electrode is checked with a meter to ensure proper functioning. Pulsing stimulus will start
      in one of the stimulating electrodes. Each time a different area is tested, the pulsing will
      be started again. Each area tested will take 10-15 minutes. The painful dermatomal
      distribution area, specific to each patient will be used for dermatomal SSEP stimulation.
      Placement will be correlated with nerve roots involved with the corresponding dermatomes.
      Measurements will be obtained to determine collision criteria.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Lack of enrollment. Futility.
  </why_stopped>
  <start_date type="Actual">January 20, 2016</start_date>
  <completion_date type="Actual">November 9, 2017</completion_date>
  <primary_completion_date type="Actual">December 7, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Positive Collision</measure>
    <time_frame>Day 1</time_frame>
    <description>Positive collision: 75% or greater decrease in amplitude from the baseline waveform. Centroparietal (CPz)-Popliteal Fossa (Fpz) cortical montage (images) will be used as primary montage to evaluate collision results.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Back Pain With Radiation</condition>
  <arm_group>
    <arm_group_label>DSSEP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>DSSEP testing after SCS trial lead placement</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DSSEP</intervention_name>
    <description>Collision testing after the placement of SCS leads</description>
    <arm_group_label>DSSEP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

        A subject will be eligible for inclusion in this study only if all the following criteria
        apply:

        A. Subject understands the procedures, agrees to participate in the study, and has signed
        and dated the informed consent form prior to the initiation of any study-related
        activities.

        B. Subjects are male or female greater than 18 years old at the time of screening visit.

        C. Pain in one or both lower extremities. D. Pain is not responding to conservative
        treatment such as physical therapy or medications.

        E. Average pain rating of at least 4 on a scale 0 to 10, on average, prior to enrollment in
        the study.

        F. Patient is mentally competent to make decisions.

        Exclusion Criteria

        A subject will not be eligible for inclusion in this study if any of the following criteria
        apply:

        A. Female subject with childbearing potential (a premenopausal female, who is not
        surgically sterile).

        B. Subjects who poorly cooperate or have any cognitive impairment. C. Patient with severe
        concomitant depression. D. Inability to communicate adequately with physician and /or study
        coordinator.

        E. Patient is diagnosed with a psychiatric condition that will likely interfere with
        diagnostic accuracy of the workup protocol or with recovery following the anticipated
        procedure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph N Atallah, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universtiy of Toledo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Toledo</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43614</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 23, 2015</study_first_submitted>
  <study_first_submitted_qc>November 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2015</study_first_posted>
  <results_first_submitted>December 5, 2017</results_first_submitted>
  <results_first_submitted_qc>January 19, 2018</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 16, 2018</results_first_posted>
  <last_update_submitted>February 19, 2018</last_update_submitted>
  <last_update_submitted_qc>February 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>lumbago</keyword>
  <keyword>low back pain</keyword>
  <keyword>leg pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The study was terminated early due to lack of enrollment.</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were recruited from subjects scheduled to receive the Spinal Cord stimulator (SCS) trial leads at the University of Toledo Medical Center.</recruitment_details>
      <pre_assignment_details>6 participants were enrolled.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>DSSEP - Dermatomal Somato Sensory Evoked Potentials</title>
          <description>DSSEP testing after SCS trial lead placement
DSSEP: Collision testing after the placement of SCS leads</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5">1 participant withdrew from the study prior to completion of DSSEP testing</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>DSSEP</title>
          <description>DSSEP testing after SCS trial lead placement
DSSEP: Collision testing after the placement of SCS leads</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="6"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="6"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="6"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Positive Collision</title>
        <description>Positive collision: 75% or greater decrease in amplitude from the baseline waveform. Centroparietal (CPz)-Popliteal Fossa (Fpz) cortical montage (images) will be used as primary montage to evaluate collision results.</description>
        <time_frame>Day 1</time_frame>
        <population>5 participants completed DSSEP testing after placement of SCS Trial leads.</population>
        <group_list>
          <group group_id="O1">
            <title>DSSEP</title>
            <description>DSSEP testing after SCS trial lead placement
DSSEP: Collision testing after the placement of SCS leads</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Positive Collision</title>
          <description>Positive collision: 75% or greater decrease in amplitude from the baseline waveform. Centroparietal (CPz)-Popliteal Fossa (Fpz) cortical montage (images) will be used as primary montage to evaluate collision results.</description>
          <population>5 participants completed DSSEP testing after placement of SCS Trial leads.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to 4 hours after DSSEP testing performed. All cause mortality not monitored/assessed.</time_frame>
      <desc>No adverse events reported. All cause mortality not monitored/assessed.</desc>
      <group_list>
        <group group_id="E1">
          <title>DSSEP</title>
          <description>DSSEP testing after SCS trial lead placement
DSSEP: Collision testing after the placement of SCS leads</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Joseph Atallah, MD</name_or_title>
      <organization>University of Toledo Medical Center</organization>
      <phone>419-383-6699</phone>
      <email>joseph.atallah@utoledo.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

